Viscosity-sensitive NIR probe for in vivo imaging of early-stage hepatic fibrosis

J Mater Chem B. 2022 Nov 9;10(43):8852-8855. doi: 10.1039/d2tb01746f.

Abstract

Herein, a viscosity-sensitive and hepatic-targeted NIR fluorescent probe has been developed for early diagnosis of hepatic fibrosis. Importantly, we observed increased liver viscosity upon CCl4-induced hepatotoxicity and decreased liver viscosity after metformin treatment, which confirmed its high clinical application prospects.

MeSH terms

  • Fluorescent Dyes / therapeutic use
  • Humans
  • Liver Cirrhosis* / chemically induced
  • Liver Cirrhosis* / diagnostic imaging
  • Metformin* / pharmacology
  • Viscosity

Substances

  • Fluorescent Dyes
  • Metformin